Antineoplastics/clarithromycin
Tumour lysis syndrome: case report
Case report
First Online:
- 54 Downloads
Reference
- Mikala G, et al. Minimal residual disease negativity after molecularly targeted venetoclax therapy of secondary plasma cell leukemia with translocation T(11;14). HemaSphere 2 (Suppl. 1): 994 abstr. PB2233, 14 Jun 2018. Available from: URL: http://doi.org/10.1097/HS9.0000000000000060 [abstract] - Hungary
Copyright information
© Springer Nature Switzerland AG 2019